144 related articles for article (PubMed ID: 31621934)
1. Declining hospitalisation and surgical intervention rates in patients with Crohn's disease: a population-based cohort.
Rahman A; Jairath V; Feagan BG; Khanna R; Shariff SZ; Allen BN; Jenkyn KB; Vinden C; Jeyarajah J; Mosli M; Benchimol E
Aliment Pharmacol Ther; 2019 Nov; 50(10):1086-1093. PubMed ID: 31621934
[TBL] [Abstract][Full Text] [Related]
2. Introduction of anti-TNF therapy has not yielded expected declines in hospitalisation and intestinal resection rates in inflammatory bowel diseases: a population-based interrupted time series study.
Murthy SK; Begum J; Benchimol EI; Bernstein CN; Kaplan GG; McCurdy JD; Singh H; Targownik L; Taljaard M
Gut; 2020 Feb; 69(2):274-282. PubMed ID: 31196874
[TBL] [Abstract][Full Text] [Related]
3. Major Abdominal and Perianal Surgery in Crohn's Disease: Long-term Follow-up of Australian Patients With Crohn's Disease.
Toh JWT; Wang N; Young CJ; Rickard MJFX; Keshava A; Stewart P; Kariyawasam V; Leong R;
Dis Colon Rectum; 2018 Jan; 61(1):67-76. PubMed ID: 29215479
[TBL] [Abstract][Full Text] [Related]
4. Comparison of infliximab with adalimumab in 827 biologic-naïve patients with Crohn's disease: a population-based Danish cohort study.
Singh S; Andersen NN; Andersson M; Loftus EV; Jess T
Aliment Pharmacol Ther; 2018 Mar; 47(5):596-604. PubMed ID: 29239001
[TBL] [Abstract][Full Text] [Related]
5. Anti-TNF treatment in Crohn's disease and risk of bowel resection-a population based cohort study.
Eberhardson M; Söderling JK; Neovius M; Cars T; Myrelid P; Ludvigsson JF; Askling J; Ekbom A; Olén O
Aliment Pharmacol Ther; 2017 Sep; 46(6):589-598. PubMed ID: 28752637
[TBL] [Abstract][Full Text] [Related]
6. The role of multimodal treatment in Crohn's disease patients with perianal fistula: a multicentre retrospective cohort study.
Sebastian S; Black C; Pugliese D; Armuzzi A; Sahnan K; Elkady SM; Katsanos KH; Christodoulou DK; Selinger C; Maconi G; Fearnhead NS; Kopylov U; Davidov Y; Bosca-Watts MM; Ellul P; Muscat M; Karmiris K; Hart AL; Danese S; Ben-Horin S; Fiorino G
Aliment Pharmacol Ther; 2018 Nov; 48(9):941-950. PubMed ID: 30226271
[TBL] [Abstract][Full Text] [Related]
7. Effects of adalimumab therapy on incidence of hospitalization and surgery in Crohn's disease: results from the CHARM study.
Feagan BG; Panaccione R; Sandborn WJ; D'Haens GR; Schreiber S; Rutgeerts PJ; Loftus EV; Lomax KG; Yu AP; Wu EQ; Chao J; Mulani P
Gastroenterology; 2008 Nov; 135(5):1493-9. PubMed ID: 18848553
[TBL] [Abstract][Full Text] [Related]
8. Remicade does not abolish the need for surgery in fistulizing Crohn's disease.
Poritz LS; Rowe WA; Koltun WA
Dis Colon Rectum; 2002 Jun; 45(6):771-5. PubMed ID: 12072629
[TBL] [Abstract][Full Text] [Related]
9. Sequential Combination Therapy Versus Monotherapy: A Lack of Benefit in Time to Inflammatory Bowel Disease-Related Surgery.
Barnes EL; Goldin A; Winter RW; Collins E; Cao B; Carrellas M; Crowell AM; Korzenik JR
Dig Dis Sci; 2016 Nov; 61(11):3261-3269. PubMed ID: 27639871
[TBL] [Abstract][Full Text] [Related]
10. Hospitalisations and surgery in Crohn's disease.
Bernstein CN; Loftus EV; Ng SC; Lakatos PL; Moum B;
Gut; 2012 Apr; 61(4):622-9. PubMed ID: 22267595
[TBL] [Abstract][Full Text] [Related]
11. Impact of the early use of immunomodulators or TNF antagonists on bowel damage and surgery in Crohn's disease.
Safroneeva E; Vavricka SR; Fournier N; Pittet V; Peyrin-Biroulet L; Straumann A; Rogler G; Schoepfer AM;
Aliment Pharmacol Ther; 2015 Oct; 42(8):977-89. PubMed ID: 26271358
[TBL] [Abstract][Full Text] [Related]
12. Temporal Trends in Surgical Resection Rates and Biologic Prescribing in Crohn's Disease: A Population-based Cohort Study.
Jenkinson PW; Plevris N; Siakavellas S; Lyons M; Arnott ID; Wilson D; Watson AJM; Jones GR; Lees CW
J Crohns Colitis; 2020 Sep; 14(9):1241-1247. PubMed ID: 32840295
[TBL] [Abstract][Full Text] [Related]
13. Shifting Health Care Use from Hospitalisations and Surgeries to Outpatient Visits in Children with Inflammatory Bowel Disease: A Population-based Cohort Study from Ontario, Canada.
Dheri AK; Kuenzig ME; Mack DR; Murthy SK; Kaplan GG; Donelle J; Smith G; Benchimol EI
J Crohns Colitis; 2021 Dec; 15(12):1991-2000. PubMed ID: 34019625
[TBL] [Abstract][Full Text] [Related]
14. Improvements in the Long-Term Outcome of Crohn's Disease Over the Past Two Decades and the Relation to Changes in Medical Management: Results from the Population-Based IBDSL Cohort.
Jeuring SF; van den Heuvel TR; Liu LY; Zeegers MP; Hameeteman WH; Romberg-Camps MJ; Oostenbrug LE; Masclee AA; Jonkers DM; Pierik MJ
Am J Gastroenterol; 2017 Feb; 112(2):325-336. PubMed ID: 27922024
[TBL] [Abstract][Full Text] [Related]
15. Dual therapy with infliximab and immunomodulator reduces one-year rates of hospitalization and surgery among veterans with inflammatory bowel disease.
Abraham NS; Richardson P; Castillo D; Kane SV
Clin Gastroenterol Hepatol; 2013 Oct; 11(10):1281-7. PubMed ID: 23792295
[TBL] [Abstract][Full Text] [Related]
16. Infliximab decreases resource use among patients with Crohn's disease.
Rubenstein JH; Chong RY; Cohen RD
J Clin Gastroenterol; 2002 Aug; 35(2):151-6. PubMed ID: 12172361
[TBL] [Abstract][Full Text] [Related]
17. Predictors of response to infliximab in paediatric perianal Crohn's disease.
Dupont-Lucas C; Dabadie A; Alberti C; Ruemmele FM;
Aliment Pharmacol Ther; 2014 Oct; 40(8):917-29. PubMed ID: 25146368
[TBL] [Abstract][Full Text] [Related]
18. Adalimumab versus infliximab in treating post-operative recurrence of Crohn's disease: a national cohort study.
Preda CM; Fulger LE; Negreanu L; Manuc M; Sandra I; Diculescu MM
Rev Esp Enferm Dig; 2016 Oct; 108(10):642-647. PubMed ID: 27651132
[TBL] [Abstract][Full Text] [Related]
19. Increased risk of developing Crohn's disease or ulcerative colitis in 17 018 patients while under treatment with anti-TNFα agents, particularly etanercept, for autoimmune diseases other than inflammatory bowel disease.
Korzenik J; Larsen MD; Nielsen J; Kjeldsen J; Nørgård BM
Aliment Pharmacol Ther; 2019 Aug; 50(3):289-294. PubMed ID: 31267570
[TBL] [Abstract][Full Text] [Related]
20. Higher anti-TNF serum levels are associated with perianal fistula closure in Crohn's disease patients.
Strik AS; Löwenberg M; Buskens CJ; B Gecse K; I Ponsioen C; Bemelman WA; D'Haens GR
Scand J Gastroenterol; 2019 Apr; 54(4):453-458. PubMed ID: 31032686
[No Abstract] [Full Text] [Related]
[Next] [New Search]
